Aflac Loads the Buyback Cannon as New Sales Signal Strength

Aflac (AFL) significantly expanded its share repurchase program by 100 million shares, bringing its total capacity to approximately 130.9 million, following $829 million in buybacks and a $0.58 dividend in Q2. This capital return initiative is supported by a robust balance sheet, including $7 billion in cash and a debt-to-capital ratio below the industry average, alongside strong operational performance with Japan sales up 18.7% in H1 2025 and improved U.S. segment margins. Despite these strengths, the Zacks Consensus Estimate projects a 5.6% decline in Aflac's 2025 earnings.

Analysis

Aflac is pursuing an aggressive capital return strategy, underscored by a 100 million share expansion to its repurchase program, bringing total capacity to approximately 130.9 million shares. This follows a substantial $829 million buyback in the second quarter and is supported by a robust balance sheet featuring $7 billion in cash and a debt-to-capital ratio of 24.7%, which is below the industry average. Operational performance provides further support, with Aflac Japan sales growing 18.7% year-over-year in the first half of 2025 and U.S. segment pre-tax profit margins improving to 21.6%. The company's dividend yield of 2.24% not only surpasses the industry average but is backed by 42 consecutive years of increases. However, this positive fundamental picture is tempered by valuation concerns and a weak forward outlook. The stock trades at a premium forward price-to-earnings ratio of 14.91 compared to the industry's 12.14, and the Zacks Consensus Estimate projects a 5.6% decline in earnings for 2025, creating a notable disconnect between current operational strength and future expectations.

Key Decisions for Investors

• Investors focused on shareholder yield should view the expanded buyback authorization and consistent, above-average dividend as a strong positive, underpinned by solid cash flow and a healthy balance sheet.
• Caution is warranted given the stock's premium valuation and the consensus forecast for a 5.6% earnings decline in 2025, suggesting potential price risk if operational momentum fails to reverse this negative outlook.
• Monitor upcoming earnings reports for evidence that sales growth in Japan and U.S. margin improvements can meaningfully outperform current analyst estimates, which will be critical for justifying the stock's valuation.